| Patients Transplanted During COVID Pandemic (n=50) | Patients Transplanted Prior to COVID Pandemic (n=482) | P-Value | |
|---|---|---|---|
| 1-Year Survival | 94.0% | 90.5% | 0.438 |
| 1-Year Freedom from CAV | 100.0% | 96.5% | 0.192 |
| 1-Year Freedom from NF-MACE | 98.0% | 86.9% | 0.024 |
| 1-Year Freedom from Any Treated Rejection | 90.0% | 84.2% | 0.262 |
| 1-Year Freedom from Acute Cellular Rejection | 90.0% | 92.1% | 0.658 |
| 1-Year Freedom from Antibody-Mediated Rejection | 94.0% | 94.8% | 0.845 |
| Average Length of Hospital Stay (Days) | 22.96 ± 37.19 | 17.21 ± 19.71 | 0.079 |
| Average Length of ICU Stay (Days) | 11.06 ± 20.61 | 8.31 ± 8.19 | 0.069 |